Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGDR2 | Q9Y5Y4 | 8/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 2/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26068380 | 0.89 | NPC1 (0.40) | PTGDR2MAPTMEN1KMT2ACYP1A2 | |
| SCHEMBL25921419 | 0.77 | PTGDR2 (0.44) | PTGDR2MAPTKMT2AHTTPOLB | |
| SCHEMBL26068383 | 0.77 | LCK (0.34) | PTGDR2MAPTMEN1KMT2ACYP1A2 | |
| SCHEMBL7593862 | 0.73 | PTGDR2 (0.53) | PTGDR2MAPTMEN1KMT2ARAB9A | |
| SCHEMBL3541536 | 0.71 | PLA2G7 (0.53) | PTGDR2MEN1KMT2AALDH1A1 | |
| SCHEMBL26068379 | 0.69 | LMNA (0.43) | MAPTMEN1KMT2ACYP1A2CYP3A4 | |
| SCHEMBL25921941 | 0.67 | PLA2G7 (0.42) | PTGDR2MAPTMEN1KMT2AHTT | |
| SCHEMBL14876186 | 0.67 | MTNR1A (0.58) | KMT2APOLBKDM4EHPGDALDH1A1 | |
| SCHEMBL4664847 | 0.66 | HSD17B10 (0.65) | MAPTMEN1KMT2AHTTPOLB | |
| SCHEMBL10222047 | 0.66 | MTNR1A (0.61) | MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230272381-A1 | SINGLE-STRANDED POLYNUCLEOTIDE | NATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIGHER EDUCATION AND RESEARCH SYSTEM (JP) | 2023-08-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230272381-A1 | SINGLE-STRANDED POLYNUCLEOTIDE | TRDMT1, ADAR, TARBP1 | PTGDR2 3374/4885MAPT 3292/4885MEN1 2412/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.